Profile for Australia Patent: 2016200598
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2016200598
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Oct 27, 2030 | Sanofi Aventis Us | JEVTANA KIT | cabazitaxel |
⤷ Sign Up | Oct 27, 2030 | Sanofi Aventis Us | JEVTANA KIT | cabazitaxel |
⤷ Sign Up | Apr 27, 2031 | Sanofi Aventis Us | JEVTANA KIT | cabazitaxel |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |